ES2119377T3 - Derivados bencisotiazoles inhibidores de la biosintesis de la 5-lipoxigenasa. - Google Patents

Derivados bencisotiazoles inhibidores de la biosintesis de la 5-lipoxigenasa.

Info

Publication number
ES2119377T3
ES2119377T3 ES95904682T ES95904682T ES2119377T3 ES 2119377 T3 ES2119377 T3 ES 2119377T3 ES 95904682 T ES95904682 T ES 95904682T ES 95904682 T ES95904682 T ES 95904682T ES 2119377 T3 ES2119377 T3 ES 2119377T3
Authority
ES
Spain
Prior art keywords
pct
sec
lipoxigenasa
bencisotiazole
biosynthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95904682T
Other languages
English (en)
Inventor
James F Eggler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2119377T3 publication Critical patent/ES2119377T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS COMPUESTOS HETEROCICLICOS LOS CUALES SON INHIBIDORES SELECTIVOS DE 5-LIPOXIGENASA (5LO).LOS NUEVOS COMPONENTES HETEROCICLICOS SON UTILES EN INHIBIR 5-LO PER SE Y EN EL TRATAMIENTO O ALIVIO DE ENFERMEDADES O ESTADOS INFLAMATORIOS O ALERGIA O ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS EN DONDE LA ENFERMEDAD O ESTADO INFLAMATORIO INCLUYE PERO NO ESTA LIMITADA A ASTMA, ARTRITIS, BROQUITIS, ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, PSORIASIS, RINITIS ALERGICA, DERMATITIS, SHOCK, DERMATITIS ATOPICA, ARTRITIS REUMATOIDE O OSTEOARTRITIS. ESTA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS UTILES DE LOS MISMOS.
ES95904682T 1994-03-28 1995-01-18 Derivados bencisotiazoles inhibidores de la biosintesis de la 5-lipoxigenasa. Expired - Lifetime ES2119377T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28

Publications (1)

Publication Number Publication Date
ES2119377T3 true ES2119377T3 (es) 1998-10-01

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95904682T Expired - Lifetime ES2119377T3 (es) 1994-03-28 1995-01-18 Derivados bencisotiazoles inhibidores de la biosintesis de la 5-lipoxigenasa.

Country Status (11)

Country Link
US (1) US5665749A (es)
EP (1) EP0752990B1 (es)
JP (1) JP2841120B2 (es)
AT (1) ATE169298T1 (es)
CA (1) CA2186513C (es)
DE (1) DE69503890T2 (es)
DK (1) DK0752990T3 (es)
ES (1) ES2119377T3 (es)
FI (1) FI963882A (es)
GR (1) GR3027598T3 (es)
WO (1) WO1995026346A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
AU637500B2 (en) * 1990-06-21 1993-05-27 Zeneca Limited Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
JP2841120B2 (ja) 1998-12-24
EP0752990A1 (en) 1997-01-15
DE69503890D1 (de) 1998-09-10
MX9604429A (es) 1997-07-31
DK0752990T3 (da) 1999-02-08
ATE169298T1 (de) 1998-08-15
FI963882A0 (fi) 1996-09-27
GR3027598T3 (en) 1998-11-30
CA2186513A1 (en) 1995-10-05
WO1995026346A1 (en) 1995-10-05
US5665749A (en) 1997-09-09
JPH09507678A (ja) 1997-08-05
EP0752990B1 (en) 1998-08-05
DE69503890T2 (de) 1998-12-10
FI963882A (fi) 1996-09-27
CA2186513C (en) 1999-03-16

Similar Documents

Publication Publication Date Title
FI945556A (fi) Tulehdustenvastaiset 3-aryyli-2-isoksatsoliinijohdannaiset
BR9408174A (pt) Compostos isoxazolina como agentes antiinflamatórios
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
SG155943A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
FI945555A (fi) Substituoituja oksindoleja
NO20005888L (no) Benzimidazolderivater som mudulatorer av IgE
YU68601A (sh) Jedinjenja i njihova upotreba za pripremu leka za tretiranje astme, alergije i inflamatornih bolesti
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
SE9900833D0 (sv) Novel combination
ES2119377T3 (es) Derivados bencisotiazoles inhibidores de la biosintesis de la 5-lipoxigenasa.
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
MX9603943A (es) Compuestos de isoxazolina como inhibidores de 5-lipooxigenasa.
ECSP003389A (es) Compuestos y procedimientos para el tratamiento de asma, alergia y transtornos inflamatorios

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 752990

Country of ref document: ES